Screening for Apoptosis Inducers in Microbial Products and Induction of Apoptosis by Cytostatin
Katsuhisa Yamazaki, Masahide Amemiya, Masaaki Ishizuka* and Tomio Takeuchi Institute for Chemotherapy, M. C. R. F., 18-24 Aza-Motono, Miyamoto, Numazu-shi, Shizuoka 410-03, Japan (Received for publication May 17, 1995) Wehave employed the DNA-methylgreen binding assay as a primary screening method for identifying apoptosis inducers in microbial products. Capsimycin, toyocamycin and cytostatin affect the binding of methylgreen to DNAof FS3 cells in this test system. The effect of cytostatin on apoptosis induction was confirmed by means of the ELISAsystem.
It is believed that apoptosis induction in tumor cells is a promising therapeutic strategy for cancer treatment1Ĥ owever,no substance has been found which acts on the primary target as an inducer of apoptosis. Wehave employed the DNA-methylgreen binding assay2) as a primary screening method for identifying apoptosis inducers in microbial products. In this way we have found that cytostatin3) is able to induce apoptosis to tumor cells. In this paper, we report screening of microbial products for apoptosis induction and the investigation of cytostatin as an inducer of apoptosis in tumor cells.
Materials and Methods
Cell Line FS3 mouse fibrosarcoma cells which had been cloned by us from spontaneously induced fibrosarcoma in the C3H/Hemouse were maintained in RPMI1640medium supplemented with 10% fetal bovine serum at 37°C in a 5% CO2 atmosphere. incubated with 10 mM5-bromo-2'-deoxy-uridine(BrdU) for 16 hours at 37°C in 5% CO2 atmosphere. After incubation, the cells were centrifuged at 250 x g for 10 minutes and resuspended in the culture medium. The cell suspension was adjusted to 1 x 105cells/ml and 100/il/ well and then transferred to a microtiter plate. The cells were incubated with lOO/il of test sample solution for 1 to 24 hours at 37°C in 5% CO2 atmosphere. After incubation, the cells were collected by centrifugation for 10 minutes at 250xg and DNA fragmentation was determined by the ELISA system.
Cytotoxicity Test

Results
In this screening system, capsimycin4), toyocamycin5) and cytostatin3), all found in microbial cultured broth, all showed cytotoxicity to FS3 cell at various concentrations, (refer Table 1 ) Capsimycin and cytostatin were morecytotoxic than toyocamycin. Capsimycin showed morepotent inhibitory activity against the binding of methylgreen to DNAof FS3 cells than cytostatin and toyocamycin. The IC50 ofcytostatin was almost the same as that of adriamycin (data not shown). As shown in Fig. 1 , cytostatin inhibited the binding of methylgreen to DNA of FS3 cells within 4 hours (>90%) and inhibition was complete at 12 hours. The effect ofcytostatin on DNAfragmentation was confirmed by ELISA. As shown in Fig. 2 , cytostatin increased the rate of DNA fragmentation in cell lysate. It appeared in cultured supernatant within 4 hours and reached at maximumby 6 hours. The results obtained by ELISA is comparable to that for the DNA/methylgreen assay.
Discussion
The programmedcell death seen in the development of organs and in the differentiation of lymphocytes has been applied in the concept of apoptosis to cancer therapy1 The effect of cytostatin on apoptosis induction in FS3 cells was confirmed by ELISA. Microscopic observation showed that apoptotic bodies were formed in FS3 cells treated with cytostatin. In a later publication we will report the effect of cytostatin on DNAfragmentation using flow cytometry, during the cell cycle of human tumorcells.
In conclusion, we have confirmed that the DNA/ methylgreen assay is valuable for the screening of apoptosis inducers and that cytostatin is an apoptosis inducer originating from a microbial source. 
